Multitude Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CUSP06 / OnCusp
CUSP06-1001, NCT06234423: A Study of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Recruiting
1
180
US
CUSP06
OnCusp Therapeutics, Inc.
Ovarian Cancer, Solid Tumor
05/27
08/27
AMT-151 / Multitude Therap
NCT05498597: AMT-151 in Patients With Selected Advanced Solid Tumours

Recruiting
1
30
RoW
AMT-151
Multitude Therapeutics Inc., Tigermed Consulting Co., Ltd
Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Ovarian Epithelial Cancer, Ovarian Endometrioid Adenocarcinoma, Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Lung Adenocarcinoma, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Pleural Mesothelioma, Ovarian Clear Cell Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Mucinous Adenocarcinoma
01/24
10/24
AMT-116 ADC / Multitude Therap
NCT06782334: AMT-116 in Patients with Solid Tumors

Recruiting
1/2
144
RoW
AMT-116
Multitude Therapeutics Inc.
Advanced Solid Tumors
06/26
12/26
AMT-116-01, NCT05725291: AMT-116 in Patients With Advanced Solid Tumors

Recruiting
1
80
US, RoW
AMT-116
Multitude Therapeutics Inc.
Advanced Solid Tumor
01/25
07/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CUSP06 / OnCusp
CUSP06-1001, NCT06234423: A Study of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Recruiting
1
180
US
CUSP06
OnCusp Therapeutics, Inc.
Ovarian Cancer, Solid Tumor
05/27
08/27
AMT-151 / Multitude Therap
NCT05498597: AMT-151 in Patients With Selected Advanced Solid Tumours

Recruiting
1
30
RoW
AMT-151
Multitude Therapeutics Inc., Tigermed Consulting Co., Ltd
Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Ovarian Epithelial Cancer, Ovarian Endometrioid Adenocarcinoma, Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Lung Adenocarcinoma, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Pleural Mesothelioma, Ovarian Clear Cell Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Mucinous Adenocarcinoma
01/24
10/24
AMT-116 ADC / Multitude Therap
NCT06782334: AMT-116 in Patients with Solid Tumors

Recruiting
1/2
144
RoW
AMT-116
Multitude Therapeutics Inc.
Advanced Solid Tumors
06/26
12/26
AMT-116-01, NCT05725291: AMT-116 in Patients With Advanced Solid Tumors

Recruiting
1
80
US, RoW
AMT-116
Multitude Therapeutics Inc.
Advanced Solid Tumor
01/25
07/25

Download Options